Abstract
In 2008, the Europe II urological device market generated revenues from
urinary incontinence device, stone management device, urological endoscope,
brachytherapy seed, and benign prostatic hyperplasia device sales in the
Benelux (Belgium, the Netherlands, and Luxembourg) and Nordic (Denmark,
Finland, Norway, and Sweden) regions, as well as Spain and Switzerland.
|